Jeffrey Jerome Ludwig
Net Worth
Last updated:
What is Jeffrey Jerome Ludwig net worth?
The estimated net worth of Mr. Jeffrey Jerome Ludwig is at least $14,609,615 as of 2 Jul 2024. He owns shares worth $603,720 as insider, has earned $175,895 from insider trading and has received compensation worth at least $13,830,000 in Puma Biotechnology, Inc..
What is the salary of Jeffrey Jerome Ludwig?
Mr. Jeffrey Jerome Ludwig salary is $4,610,000 per year as Chief Commercial Officer in Puma Biotechnology, Inc..
How old is Jeffrey Jerome Ludwig?
Mr. Jeffrey Jerome Ludwig is 59 years old, born in 1966.
What stocks does Jeffrey Jerome Ludwig currently own?
As insider, Mr. Jeffrey Jerome Ludwig owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Puma Biotechnology, Inc. (PBYI) | Chief Commercial Officer | 120,986 | $4.99 | $603,720 |
What does Puma Biotechnology, Inc. do?
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Jeffrey Jerome Ludwig insider trading
Puma Biotechnology, Inc.
Mr. Jeffrey Jerome Ludwig has made 6 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he sold 6,051 units of PBYI stock worth $19,781 on 2 Jul 2024.
The largest trade he's ever made was exercising 12,956 units of PBYI stock on 3 Jan 2024. As of 2 Jul 2024 he still owns at least 120,986 units of PBYI stock.
Puma Biotechnology key executives
Puma Biotechnology, Inc. executives and other stock owners filed with the SEC:
- Mr. Alan H. Auerbach (55) Founder, Chairman, Pres, Chief Executive Officer & Sec.
- Mr. Douglas Hunt B.Sc., FRAPS (60) Senior Vice President of Regulatory Affairs, Medical Writing & Project Management
- Mr. Jeffrey Jerome Ludwig (59) Chief Commercial Officer
- Mr. Maximo F. Nougues (56) Chief Financial Officer & Principal Accounting Officer